• Home
  1. Home
  2. Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: a phase I/II trial
Scientific article
English

Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: a phase I/II trial

Contributors

Hess, Viviane; Salzberg, Marc; Borner, Markus; Morant, Rudolf; Roth, Arnaud; Ludwig, Christian; Herrmann, Richard

Published in

Journal of clinical oncology, vol. 21, no. 1, p. 66-68

Publication date

2003

Abstract

Preclinical studies indicate positive interactions between capecitabine, an oral fluorouracil precursor, and gemcitabine, the current standard treatment for advanced pancreatic carcinoma (APC). In this study, we investigated the addition of capecitabine to gemcitabine treatment for patients with APC.

Keywords

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols/adverse effects/therapeutic use
  • Deoxycytidine/administration & dosage/adverse effects/analogs & derivatives
  • Female
  • Fluorouracil/analogs & derivatives
  • Humans
  • Male
  • Maximum Tolerated Dose
  • Middle Aged
  • Pancreatic Neoplasms/drug therapy/mortality
  • Survival Rate
  • Switzerland/epidemiology

UNIGE affiliation entities

UNIGE research groups

Citation (ISO format)

HESS, Viviane et al. Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: a phase I/II trial. In: Journal of clinical oncology, 2003, vol. 21, n° 1, p. 66–68. doi: 10.1200/JCO.2003.04.029

Main files (1)

Article (Published version)

Identifiers

Additional URL for this publication

http://jco.ascopubs.org/content/21/1/66.long

Journal ISSN

0732-183X
532views
0downloads

Technical informations

Creation

13/01/2015 13:04:00

First validation

13/01/2015 13:04:00

Update

12/03/2026 10:47:17

Status update

12/03/2026 10:47:17

Last indexation

12/03/2026 10:53:07
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated